This report aims to provide a comprehensive presentation of the global market for Prostate Cancer Hormone Therapy, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Prostate Cancer Hormone Therapy. This report contains market size and forecasts of Prostate Cancer Hormone Therapy in global, including the following market information:
Global Prostate Cancer Hormone Therapy Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
The global Prostate Cancer Hormone Therapy market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
Tablet Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Prostate Cancer Hormone Therapy include Pfizer, Astellas, Johnson & Johnson, AstraZeneca, Bayer, Merck, Tolmar, Zoladex and Ferring Pharmaceuticals, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Prostate Cancer Hormone Therapy companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Prostate Cancer Hormone Therapy Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global Prostate Cancer Hormone Therapy Market Segment Percentages, by Type, 2022 (%)
Tablet
Injection
Global Prostate Cancer Hormone Therapy Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global Prostate Cancer Hormone Therapy Market Segment Percentages, by Application, 2022 (%)
Hospital
Clinic
Others
Global Prostate Cancer Hormone Therapy Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global Prostate Cancer Hormone Therapy Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Prostate Cancer Hormone Therapy revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Prostate Cancer Hormone Therapy revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Pfizer
Astellas
Johnson & Johnson
AstraZeneca
Bayer
Merck
Tolmar
Zoladex
Ferring Pharmaceuticals
Jiangsu Hengrui Pharmaceuticals
CTTQ
Outline of Major Chapters:
Chapter 1: Introduces the definition of Prostate Cancer Hormone Therapy, market overview.
Chapter 2: Global Prostate Cancer Hormone Therapy market size in revenue.
Chapter 3: Detailed analysis of Prostate Cancer Hormone Therapy company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Prostate Cancer Hormone Therapy in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Prostate Cancer Hormone Therapy Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Prostate Cancer Hormone Therapy Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Prostate Cancer Hormone Therapy Overall Market Size
2.1 Global Prostate Cancer Hormone Therapy Market Size: 2022 VS 2029
2.2 Global Prostate Cancer Hormone Therapy Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Prostate Cancer Hormone Therapy Players in Global Market
3.2 Top Global Prostate Cancer Hormone Therapy Companies Ranked by Revenue
3.3 Global Prostate Cancer Hormone Therapy Revenue by Companies
3.4 Top 3 and Top 5 Prostate Cancer Hormone Therapy Companies in Global Market, by Revenue in 2022
3.5 Global Companies Prostate Cancer Hormone Therapy Product Type
3.6 Tier 1, Tier 2 and Tier 3 Prostate Cancer Hormone Therapy Players in Global Market
3.6.1 List of Global Tier 1 Prostate Cancer Hormone Therapy Companies
3.6.2 List of Global Tier 2 and Tier 3 Prostate Cancer Hormone Therapy Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Prostate Cancer Hormone Therapy Market Size Markets, 2022 & 2029
4.1.2 Tablet
4.1.3 Injection
4.2 By Type - Global Prostate Cancer Hormone Therapy Revenue & Forecasts
4.2.1 By Type - Global Prostate Cancer Hormone Therapy Revenue, 2018-2023
4.2.2 By Type - Global Prostate Cancer Hormone Therapy Revenue, 2024-2029
4.2.3 By Type - Global Prostate Cancer Hormone Therapy Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Prostate Cancer Hormone Therapy Market Size, 2022 & 2029
5.1.2 Hospital
5.1.3 Clinic
5.1.4 Others
5.2 By Application - Global Prostate Cancer Hormone Therapy Revenue & Forecasts
5.2.1 By Application - Global Prostate Cancer Hormone Therapy Revenue, 2018-2023
5.2.2 By Application - Global Prostate Cancer Hormone Therapy Revenue, 2024-2029
5.2.3 By Application - Global Prostate Cancer Hormone Therapy Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region - Global Prostate Cancer Hormone Therapy Market Size, 2022 & 2029
6.2 By Region - Global Prostate Cancer Hormone Therapy Revenue & Forecasts
6.2.1 By Region - Global Prostate Cancer Hormone Therapy Revenue, 2018-2023
6.2.2 By Region - Global Prostate Cancer Hormone Therapy Revenue, 2024-2029
6.2.3 By Region - Global Prostate Cancer Hormone Therapy Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country - North America Prostate Cancer Hormone Therapy Revenue, 2018-2029
6.3.2 US Prostate Cancer Hormone Therapy Market Size, 2018-2029
6.3.3 Canada Prostate Cancer Hormone Therapy Market Size, 2018-2029
6.3.4 Mexico Prostate Cancer Hormone Therapy Market Size, 2018-2029
6.4 Europe
6.4.1 By Country - Europe Prostate Cancer Hormone Therapy Revenue, 2018-2029
6.4.2 Germany Prostate Cancer Hormone Therapy Market Size, 2018-2029
6.4.3 France Prostate Cancer Hormone Therapy Market Size, 2018-2029
6.4.4 U.K. Prostate Cancer Hormone Therapy Market Size, 2018-2029
6.4.5 Italy Prostate Cancer Hormone Therapy Market Size, 2018-2029
6.4.6 Russia Prostate Cancer Hormone Therapy Market Size, 2018-2029
6.4.7 Nordic Countries Prostate Cancer Hormone Therapy Market Size, 2018-2029
6.4.8 Benelux Prostate Cancer Hormone Therapy Market Size, 2018-2029
6.5 Asia
6.5.1 By Region - Asia Prostate Cancer Hormone Therapy Revenue, 2018-2029
6.5.2 China Prostate Cancer Hormone Therapy Market Size, 2018-2029
6.5.3 Japan Prostate Cancer Hormone Therapy Market Size, 2018-2029
6.5.4 South Korea Prostate Cancer Hormone Therapy Market Size, 2018-2029
6.5.5 Southeast Asia Prostate Cancer Hormone Therapy Market Size, 2018-2029
6.5.6 India Prostate Cancer Hormone Therapy Market Size, 2018-2029
6.6 South America
6.6.1 By Country - South America Prostate Cancer Hormone Therapy Revenue, 2018-2029
6.6.2 Brazil Prostate Cancer Hormone Therapy Market Size, 2018-2029
6.6.3 Argentina Prostate Cancer Hormone Therapy Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Prostate Cancer Hormone Therapy Revenue, 2018-2029
6.7.2 Turkey Prostate Cancer Hormone Therapy Market Size, 2018-2029
6.7.3 Israel Prostate Cancer Hormone Therapy Market Size, 2018-2029
6.7.4 Saudi Arabia Prostate Cancer Hormone Therapy Market Size, 2018-2029
6.7.5 UAE Prostate Cancer Hormone Therapy Market Size, 2018-2029
7 Prostate Cancer Hormone Therapy Companies Profiles
7.1 Pfizer
7.1.1 Pfizer Company Summary
7.1.2 Pfizer Business Overview
7.1.3 Pfizer Prostate Cancer Hormone Therapy Major Product Offerings
7.1.4 Pfizer Prostate Cancer Hormone Therapy Revenue in Global Market (2018-2023)
7.1.5 Pfizer Key News & Latest Developments
7.2 Astellas
7.2.1 Astellas Company Summary
7.2.2 Astellas Business Overview
7.2.3 Astellas Prostate Cancer Hormone Therapy Major Product Offerings
7.2.4 Astellas Prostate Cancer Hormone Therapy Revenue in Global Market (2018-2023)
7.2.5 Astellas Key News & Latest Developments
7.3 Johnson & Johnson
7.3.1 Johnson & Johnson Company Summary
7.3.2 Johnson & Johnson Business Overview
7.3.3 Johnson & Johnson Prostate Cancer Hormone Therapy Major Product Offerings
7.3.4 Johnson & Johnson Prostate Cancer Hormone Therapy Revenue in Global Market (2018-2023)
7.3.5 Johnson & Johnson Key News & Latest Developments
7.4 AstraZeneca
7.4.1 AstraZeneca Company Summary
7.4.2 AstraZeneca Business Overview
7.4.3 AstraZeneca Prostate Cancer Hormone Therapy Major Product Offerings
7.4.4 AstraZeneca Prostate Cancer Hormone Therapy Revenue in Global Market (2018-2023)
7.4.5 AstraZeneca Key News & Latest Developments
7.5 Bayer
7.5.1 Bayer Company Summary
7.5.2 Bayer Business Overview
7.5.3 Bayer Prostate Cancer Hormone Therapy Major Product Offerings
7.5.4 Bayer Prostate Cancer Hormone Therapy Revenue in Global Market (2018-2023)
7.5.5 Bayer Key News & Latest Developments
7.6 Merck
7.6.1 Merck Company Summary
7.6.2 Merck Business Overview
7.6.3 Merck Prostate Cancer Hormone Therapy Major Product Offerings
7.6.4 Merck Prostate Cancer Hormone Therapy Revenue in Global Market (2018-2023)
7.6.5 Merck Key News & Latest Developments
7.7 Tolmar
7.7.1 Tolmar Company Summary
7.7.2 Tolmar Business Overview
7.7.3 Tolmar Prostate Cancer Hormone Therapy Major Product Offerings
7.7.4 Tolmar Prostate Cancer Hormone Therapy Revenue in Global Market (2018-2023)
7.7.5 Tolmar Key News & Latest Developments
7.8 Zoladex
7.8.1 Zoladex Company Summary
7.8.2 Zoladex Business Overview
7.8.3 Zoladex Prostate Cancer Hormone Therapy Major Product Offerings
7.8.4 Zoladex Prostate Cancer Hormone Therapy Revenue in Global Market (2018-2023)
7.8.5 Zoladex Key News & Latest Developments
7.9 Ferring Pharmaceuticals
7.9.1 Ferring Pharmaceuticals Company Summary
7.9.2 Ferring Pharmaceuticals Business Overview
7.9.3 Ferring Pharmaceuticals Prostate Cancer Hormone Therapy Major Product Offerings
7.9.4 Ferring Pharmaceuticals Prostate Cancer Hormone Therapy Revenue in Global Market (2018-2023)
7.9.5 Ferring Pharmaceuticals Key News & Latest Developments
7.10 Jiangsu Hengrui Pharmaceuticals
7.10.1 Jiangsu Hengrui Pharmaceuticals Company Summary
7.10.2 Jiangsu Hengrui Pharmaceuticals Business Overview
7.10.3 Jiangsu Hengrui Pharmaceuticals Prostate Cancer Hormone Therapy Major Product Offerings
7.10.4 Jiangsu Hengrui Pharmaceuticals Prostate Cancer Hormone Therapy Revenue in Global Market (2018-2023)
7.10.5 Jiangsu Hengrui Pharmaceuticals Key News & Latest Developments
7.11 CTTQ
7.11.1 CTTQ Company Summary
7.11.2 CTTQ Business Overview
7.11.3 CTTQ Prostate Cancer Hormone Therapy Major Product Offerings
7.11.4 CTTQ Prostate Cancer Hormone Therapy Revenue in Global Market (2018-2023)
7.11.5 CTTQ Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Prostate Cancer Hormone Therapy Market Opportunities & Trends in Global Market
Table 2. Prostate Cancer Hormone Therapy Market Drivers in Global Market
Table 3. Prostate Cancer Hormone Therapy Market Restraints in Global Market
Table 4. Key Players of Prostate Cancer Hormone Therapy in Global Market
Table 5. Top Prostate Cancer Hormone Therapy Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Prostate Cancer Hormone Therapy Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Prostate Cancer Hormone Therapy Revenue Share by Companies, 2018-2023
Table 8. Global Companies Prostate Cancer Hormone Therapy Product Type
Table 9. List of Global Tier 1 Prostate Cancer Hormone Therapy Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Prostate Cancer Hormone Therapy Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Prostate Cancer Hormone Therapy Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Prostate Cancer Hormone Therapy Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Prostate Cancer Hormone Therapy Revenue in Global (US$, Mn), 2024-2029
Table 14. By Application ? Global Prostate Cancer Hormone Therapy Revenue, (US$, Mn), 2022 & 2029
Table 15. By Application - Prostate Cancer Hormone Therapy Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Prostate Cancer Hormone Therapy Revenue in Global (US$, Mn), 2024-2029
Table 17. By Region ? Global Prostate Cancer Hormone Therapy Revenue, (US$, Mn), 2022 & 2029
Table 18. By Region - Global Prostate Cancer Hormone Therapy Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Prostate Cancer Hormone Therapy Revenue (US$, Mn), 2024-2029
Table 20. By Country - North America Prostate Cancer Hormone Therapy Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Prostate Cancer Hormone Therapy Revenue, (US$, Mn), 2024-2029
Table 22. By Country - Europe Prostate Cancer Hormone Therapy Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Prostate Cancer Hormone Therapy Revenue, (US$, Mn), 2024-2029
Table 24. By Region - Asia Prostate Cancer Hormone Therapy Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Prostate Cancer Hormone Therapy Revenue, (US$, Mn), 2024-2029
Table 26. By Country - South America Prostate Cancer Hormone Therapy Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Prostate Cancer Hormone Therapy Revenue, (US$, Mn), 2024-2029
Table 28. By Country - Middle East & Africa Prostate Cancer Hormone Therapy Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Prostate Cancer Hormone Therapy Revenue, (US$, Mn), 2024-2029
Table 30. Pfizer Company Summary
Table 31. Pfizer Prostate Cancer Hormone Therapy Product Offerings
Table 32. Pfizer Prostate Cancer Hormone Therapy Revenue (US$, Mn) & (2018-2023)
Table 33. Pfizer Key News & Latest Developments
Table 34. Astellas Company Summary
Table 35. Astellas Prostate Cancer Hormone Therapy Product Offerings
Table 36. Astellas Prostate Cancer Hormone Therapy Revenue (US$, Mn) & (2018-2023)
Table 37. Astellas Key News & Latest Developments
Table 38. Johnson & Johnson Company Summary
Table 39. Johnson & Johnson Prostate Cancer Hormone Therapy Product Offerings
Table 40. Johnson & Johnson Prostate Cancer Hormone Therapy Revenue (US$, Mn) & (2018-2023)
Table 41. Johnson & Johnson Key News & Latest Developments
Table 42. AstraZeneca Company Summary
Table 43. AstraZeneca Prostate Cancer Hormone Therapy Product Offerings
Table 44. AstraZeneca Prostate Cancer Hormone Therapy Revenue (US$, Mn) & (2018-2023)
Table 45. AstraZeneca Key News & Latest Developments
Table 46. Bayer Company Summary
Table 47. Bayer Prostate Cancer Hormone Therapy Product Offerings
Table 48. Bayer Prostate Cancer Hormone Therapy Revenue (US$, Mn) & (2018-2023)
Table 49. Bayer Key News & Latest Developments
Table 50. Merck Company Summary
Table 51. Merck Prostate Cancer Hormone Therapy Product Offerings
Table 52. Merck Prostate Cancer Hormone Therapy Revenue (US$, Mn) & (2018-2023)
Table 53. Merck Key News & Latest Developments
Table 54. Tolmar Company Summary
Table 55. Tolmar Prostate Cancer Hormone Therapy Product Offerings
Table 56. Tolmar Prostate Cancer Hormone Therapy Revenue (US$, Mn) & (2018-2023)
Table 57. Tolmar Key News & Latest Developments
Table 58. Zoladex Company Summary
Table 59. Zoladex Prostate Cancer Hormone Therapy Product Offerings
Table 60. Zoladex Prostate Cancer Hormone Therapy Revenue (US$, Mn) & (2018-2023)
Table 61. Zoladex Key News & Latest Developments
Table 62. Ferring Pharmaceuticals Company Summary
Table 63. Ferring Pharmaceuticals Prostate Cancer Hormone Therapy Product Offerings
Table 64. Ferring Pharmaceuticals Prostate Cancer Hormone Therapy Revenue (US$, Mn) & (2018-2023)
Table 65. Ferring Pharmaceuticals Key News & Latest Developments
Table 66. Jiangsu Hengrui Pharmaceuticals Company Summary
Table 67. Jiangsu Hengrui Pharmaceuticals Prostate Cancer Hormone Therapy Product Offerings
Table 68. Jiangsu Hengrui Pharmaceuticals Prostate Cancer Hormone Therapy Revenue (US$, Mn) & (2018-2023)
Table 69. Jiangsu Hengrui Pharmaceuticals Key News & Latest Developments
Table 70. CTTQ Company Summary
Table 71. CTTQ Prostate Cancer Hormone Therapy Product Offerings
Table 72. CTTQ Prostate Cancer Hormone Therapy Revenue (US$, Mn) & (2018-2023)
Table 73. CTTQ Key News & Latest Developments
List of Figures
Figure 1. Prostate Cancer Hormone Therapy Segment by Type in 2022
Figure 2. Prostate Cancer Hormone Therapy Segment by Application in 2022
Figure 3. Global Prostate Cancer Hormone Therapy Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Prostate Cancer Hormone Therapy Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Prostate Cancer Hormone Therapy Revenue, 2018-2029 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Prostate Cancer Hormone Therapy Revenue in 2022
Figure 8. By Type - Global Prostate Cancer Hormone Therapy Revenue Market Share, 2018-2029
Figure 9. By Application - Global Prostate Cancer Hormone Therapy Revenue Market Share, 2018-2029
Figure 10. By Type - Global Prostate Cancer Hormone Therapy Revenue, (US$, Mn), 2022 & 2029
Figure 11. By Type - Global Prostate Cancer Hormone Therapy Revenue Market Share, 2018-2029
Figure 12. By Application - Global Prostate Cancer Hormone Therapy Revenue, (US$, Mn), 2022 & 2029
Figure 13. By Application - Global Prostate Cancer Hormone Therapy Revenue Market Share, 2018-2029
Figure 14. By Region - Global Prostate Cancer Hormone Therapy Revenue Market Share, 2018-2029
Figure 15. By Country - North America Prostate Cancer Hormone Therapy Revenue Market Share, 2018-2029
Figure 16. US Prostate Cancer Hormone Therapy Revenue, (US$, Mn), 2018-2029
Figure 17. Canada Prostate Cancer Hormone Therapy Revenue, (US$, Mn), 2018-2029
Figure 18. Mexico Prostate Cancer Hormone Therapy Revenue, (US$, Mn), 2018-2029
Figure 19. By Country - Europe Prostate Cancer Hormone Therapy Revenue Market Share, 2018-2029
Figure 20. Germany Prostate Cancer Hormone Therapy Revenue, (US$, Mn), 2018-2029
Figure 21. France Prostate Cancer Hormone Therapy Revenue, (US$, Mn), 2018-2029
Figure 22. U.K. Prostate Cancer Hormone Therapy Revenue, (US$, Mn), 2018-2029
Figure 23. Italy Prostate Cancer Hormone Therapy Revenue, (US$, Mn), 2018-2029
Figure 24. Russia Prostate Cancer Hormone Therapy Revenue, (US$, Mn), 2018-2029
Figure 25. Nordic Countries Prostate Cancer Hormone Therapy Revenue, (US$, Mn), 2018-2029
Figure 26. Benelux Prostate Cancer Hormone Therapy Revenue, (US$, Mn), 2018-2029
Figure 27. By Region - Asia Prostate Cancer Hormone Therapy Revenue Market Share, 2018-2029
Figure 28. China Prostate Cancer Hormone Therapy Revenue, (US$, Mn), 2018-2029
Figure 29. Japan Prostate Cancer Hormone Therapy Revenue, (US$, Mn), 2018-2029
Figure 30. South Korea Prostate Cancer Hormone Therapy Revenue, (US$, Mn), 2018-2029
Figure 31. Southeast Asia Prostate Cancer Hormone Therapy Revenue, (US$, Mn), 2018-2029
Figure 32. India Prostate Cancer Hormone Therapy Revenue, (US$, Mn), 2018-2029
Figure 33. By Country - South America Prostate Cancer Hormone Therapy Revenue Market Share, 2018-2029
Figure 34. Brazil Prostate Cancer Hormone Therapy Revenue, (US$, Mn), 2018-2029
Figure 35. Argentina Prostate Cancer Hormone Therapy Revenue, (US$, Mn), 2018-2029
Figure 36. By Country - Middle East & Africa Prostate Cancer Hormone Therapy Revenue Market Share, 2018-2029
Figure 37. Turkey Prostate Cancer Hormone Therapy Revenue, (US$, Mn), 2018-2029
Figure 38. Israel Prostate Cancer Hormone Therapy Revenue, (US$, Mn), 2018-2029
Figure 39. Saudi Arabia Prostate Cancer Hormone Therapy Revenue, (US$, Mn), 2018-2029
Figure 40. UAE Prostate Cancer Hormone Therapy Revenue, (US$, Mn), 2018-2029
Figure 41. Pfizer Prostate Cancer Hormone Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Astellas Prostate Cancer Hormone Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Johnson & Johnson Prostate Cancer Hormone Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. AstraZeneca Prostate Cancer Hormone Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Bayer Prostate Cancer Hormone Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. Merck Prostate Cancer Hormone Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. Tolmar Prostate Cancer Hormone Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. Zoladex Prostate Cancer Hormone Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. Ferring Pharmaceuticals Prostate Cancer Hormone Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 50. Jiangsu Hengrui Pharmaceuticals Prostate Cancer Hormone Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 51. CTTQ Prostate Cancer Hormone Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
